Collaborations & PartnershipsNF1Press ReleaseScience & Research SpringWorks Therapeutics Announces FDA Fast Track Designation for PD-0325901 for NF1 Patients
Collaborations & PartnershipsNF2-SWNPress ReleaseScience & Research Children’s Tumor Foundation Provides Funding to NF2 Therapeutics, Inc. to Develop a First-in-Class Gene Therapy for NF2-related schwannomatosis
NF2-SWNPress ReleaseScience & Research Children’s Tumor Foundation Launches NF2 Accelerator Initiative to Combat Rare Genetic Disorder
Collaborations & PartnershipsNF1Press ReleasePublicationsScience & Research Nerve Fibers in Skin Are Involved in Initiating Neurofibromas in Patients with Disfiguring Neurofibromatosis 1
NF1PublicationsScience & Research Updated guidelines published about NF1 diagnosis and management in children
Collaborations & PartnershipsNF1PublicationsScience & Research Research Published from Synodos Group Developing Pig Models
